SEC Form 4 · accession 0001230724-26-000012
Vaxcyte, Inc. · PCVX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew Guggenhime
Officer — PRESIDENT AND CFO
Period of report
Jul 6, 2026
Accepted (ET)
Jul 6, 2026 · 7:31 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001649094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 6, 2026 | M | 10,000 | $5.35 | A | 114,395 | D | |
| Common StockF2 | Jul 6, 2026 | S | 7,913 | $57.157 | D | 106,482 | D | |
| Common StockF3 | Jul 6, 2026 | S | 2,087 | $57.764 | D | 104,395 | D | |
| Common StockF4 | holding | — | — | — | 61,850 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F5 | $5.35 | Jul 6, 2026 | M | 10,000 | D | — | May 11, 2030 | Common Stock | 10,000 | 226,827 | D |
Explanation of responses
- F1The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 4, 2026.
- F2The price reported is a weighted-average price. The shares were sold at prices ranging from $56.595 to $57.59. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The price reported is a weighted-average price. The shares were sold at prices ranging from $57.61 to $58.32. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4Shares are held by ALG 2025 GRAT HOLDINGS LLC, of which 100% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person is the annuitant and the trustee.
- F5Option is fully vested and exercisable.